4 medicines held by Alexion Europe S.A.S. on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Ultomiris 1 100 mg/11 mL concentrate for solution for infusion EU/1/19/1371/003 |
RAVULIZUMAB | Alexion Europe S.A.S. | — |
| Ultomiris 300 mg/3 mL concentrate for solution for infusion EU/1/19/1371/002 |
RAVULIZUMAB | Alexion Europe S.A.S. | — |
| Voydeya 100 mg film-coated tablets EU/1/24/1792/003-004 |
Danicopan | Alexion Europe S.A.S. | — |
| Voydeya 50 mg + 100 mg film-coated tablets EU/1/24/1792/001-002 |
Danicopan | Alexion Europe S.A.S. | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 16 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.